Griffiths, "The human serum resistance associated gene is ubiquitous and conserved in Trypanosoma brucei rhodesiense
throughout East Africa," Infection, Genetics and Evolution, vol.
The Human African trypanosomiasis or sleeping sickness, a fatal and neglected tropical disease, is caused by two parasites Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense
. This disease is transmitted by tsetse fly (genus Glossina), a vector which is only found in tropical Africa, this explains the T.
However, it has been reported that the anaemia caused by the human infective Trypanosoma brucei rhodesiense
and Trypanosoma brucei gambiense in rodents ranges between macrocytic normochromic to microcytic hypochromic anaemia .
The authors would like to acknowledge: Team of Drug for Neglected Diseases Initiative (DNDi), Professor Reto Brun and Tanja Wenzler from the Swiss Tropical and Public Health Institute for guidance in the bioassay transfer and for providing the Trypanosoma brucei rhodesiense
Matovu, "A search for Trypanosoma brucei rhodesiense
diagnostic antigens by proteomic screening and targeted cloning," PLoS ONE, vol.
Human African trypanosomiasis (HAT) is a tropical infectious disease caused by the protozoan parasites Trypanosoma brucei rhodesiense
and T b.
The origins of a new Trypanosoma brucei rhodesiense
sleeping sickness outbreak in eastern Uganda.
Human African trypanosomiasis (HAT) cases are caused by the parasites Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense
, which are indigenous to west and central Africa.
(2,3) There are two forms of illness: a more chronic infection caused by the protozoan parasite Trypanosoma brucei rhodesiense
(West African) and a more acute disease caused by Trypanosoma brucei gambiense (East African).
Artemisinins inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense
in vitro growth.
Maina, "Occurrence of multiple drug resistance in Trypanosoma brucei rhodesiense
isolated from sleeping sickness patients," Onderstepoort Journal of Veterinary Research, vol.
Marchantin A inhibited proliferation of the Plasmodium falciparum strains, NF54 ([IC.sub.50] = 3.41 [micro]M) and K1 ([IC.sub.50] = 2.02 [micro]M) and showed activity against other protozoan species Trypanosoma brucei rhodesiense